{"id":772643,"date":"2023-07-26T12:25:50","date_gmt":"2023-07-26T16:25:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/"},"modified":"2023-07-26T12:25:50","modified_gmt":"2023-07-26T16:25:50","slug":"agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/","title":{"rendered":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023"},"content":{"rendered":"

\nLive Conference Call and Webcast at 8:30 a.m. ET
\n<\/h2>\n
\n

PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2023 financial results before the market open on\u00a0Wednesday, August 9, 2023. Following the release, the Company will host a live conference call and webcast at\u00a08:30 a.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update.<\/p>\n\n\n\n\n\n
Event<\/td>\nAgile Therapeutics Second Quarter 2023 Financial Results Conference Call<\/td>\n<\/tr>\n
Date<\/td>\nWednesday, August 9, 2023<\/td>\n<\/tr>\n
Time<\/td>\n8:30 a.m. ET \/ 5:30 a.m. PT<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations<\/a>. To participate in the live conference call via telephone, please register\u00a0here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.<\/p>\n

\n About<\/strong>
\n Agile<\/strong>
\n Therapeutics,<\/strong>
\n Inc.<\/strong>\n <\/p>\n

Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla\u00ae<\/sup>, (levonorgestrel and ethinyl estradiol) transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae<\/sup>, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com<\/u><\/strong>. <\/a>The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website, Twitter account (@agilether<\/a>), and LinkedIn<\/a> account.<\/p>\n

\n Contact:<\/strong>
\n
Matt Riley<\/p>\n

Head of Investor Relations & Corporate Communications<\/p>\n

\n mriley@agiletherapeutics.com<\/a>\n <\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2023 financial results before the market open on\u00a0Wednesday, August 9, 2023. Following the release, the Company will host a live conference call and webcast at\u00a08:30 a.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics Second Quarter 2023 Financial Results Conference Call Date Wednesday, August 9, 2023 Time 8:30 a.m. ET \/ 5:30 a.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live … <\/p>\n

Continue reading “Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772643","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAgile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2023 financial results before the market open on\u00a0Wednesday, August 9, 2023. Following the release, the Company will host a live conference call and webcast at\u00a08:30 a.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics Second Quarter 2023 Financial Results Conference Call Date Wednesday, August 9, 2023 Time 8:30 a.m. ET \/ 5:30 a.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live … Continue reading "Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-26T16:25:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023\",\"datePublished\":\"2023-07-26T16:25:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/\",\"name\":\"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=\",\"datePublished\":\"2023-07-26T16:25:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk","og_description":"Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women’s healthcare company, today announced it will report second quarter 2023 financial results before the market open on\u00a0Wednesday, August 9, 2023. Following the release, the Company will host a live conference call and webcast at\u00a08:30 a.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics Second Quarter 2023 Financial Results Conference Call Date Wednesday, August 9, 2023 Time 8:30 a.m. ET \/ 5:30 a.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live … Continue reading \"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-26T16:25:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023","datePublished":"2023-07-26T16:25:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/","name":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=","datePublished":"2023-07-26T16:25:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3ODgzNCM1NzAzOTU3IzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2023-financial-results-and-provide-business-plan-updates-on-wednesday-august-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772643"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772643\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}